Nalaganje...
Androgen receptor decoy molecules block the growth of prostate cancer
The androgen receptor (AR) is activated by both ligand-dependent and -independent mechanisms. Current therapies for prostate cancer target the ligand-binding domain in the C terminus of the AR. However, ligand-independent activation of the AR occurs by the N-terminal domain (NTD), making the NTD a p...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
National Academy of Sciences
2007
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1783142/ https://ncbi.nlm.nih.gov/pubmed/17227854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0606718104 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|